Administration of N-acetylcysteine Attenuates Post-Myocardial Infarction Remodeling

pp. 28-34

Abstract

Background: Ischemic heart disease is the main cause of death in Argentina. The prevailing form of presentation is myocardial infarction (MI), characterized by insufficient blood perfusion, cell death and loss of contractile mass. The evolution of ventricular remodeling causes ventricular dilation, hemodynamic impairment, heart failure, and decreased survival. The oxidative stress occurring during this process could be attenuated by the administration of N-acetyl cysteine (NAC) through increased glutathione levels.

Objective: The aim of this study was to evaluate the effect of NAC administration on post-MI remodeling.

Methods: New Zealand rabbits were divided into three experimental groups: Control, MI and MI+NAC. A left thoracotomy was performed under general anesthesia, and in the MI groups a branch of the left coronary artery was ligated. Echocardiographic, hemodynamic and morphological studies of the left ventricle were performed at the end of the 28-day post infarction follow-up period.

Results: In the MI and MI+NAC groups, the infarcts were located in the left ventricular free wall and had similar sizes. The administration of NAC prevented non-infarcted area thinning and decreased the dilation caused by the infarction. It also preserved left ventricular systolic and diastolic functions, attenuating the impairment that they suffered as a consequence of the infarction.

Conclusion: These results suggest that NAC administration is a promising therapy to mitigate the unfavorable effects of post-MI remodeling.

How to cite this article:

Rodríguez M, Pidal G, Buzzano O, Damonte M, Lago N, Lightowler C, y cols. La administración de N-acetilcisteína atenúa el remodelado post- infarto de miocardio. Rev Argent Cardiol 2024;92:28-34. http://dx.doi.org/10.7775/rac.es.v92.i1.20726